Stay updated on Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial

Sign up to get notified when there's something new on the Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T20:12:34.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now displayed and the prior revision (v3.4.1) was removed. This change does not affect study details, eligibility criteria, or outcomes on the page.
    Difference
    0.4%
    Check dated 2026-02-11T04:50:13.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding is now displayed, and the page revision has been updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T03:42:48.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Additions include showing the glossary and new status fields such as Results First Posted, Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0; deletions remove Results First Posted (Estimated), Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-28T00:42:38.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Results updates were added, including Clinical Benefit Rate (CBR) in PD-1 naive patients, overall survival (OS), progression-free survival (PFS), and brain-specific safety data, with the corresponding submission dates. Study documents such as the Protocol and Statistical Analysis Plan PDF were also added to the page.
    Difference
    3%
    Check dated 2026-01-14T01:48:08.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Added a Locations section displaying Texas as a study location and removed the Texas Locations and HHS Vulnerability Disclosure links.
    Difference
    0.2%
    Check dated 2025-12-23T13:33:47.000Z thumbnail image

Stay in the know with updates to Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial page.